Integra LifeSciences Holdings Gross Margin 2010-2024 | IART
Current and historical gross margin for Integra LifeSciences Holdings (IART) over the last 10 years. The current gross profit margin for Integra LifeSciences Holdings as of December 31, 2024 is %.
| Integra LifeSciences Holdings Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-12-31 | $1.61B | $0.88B | 54.75% |
| 2024-09-30 | $1.57B | $0.86B | 54.89% |
| 2024-06-30 | $1.57B | $0.88B | 56.00% |
| 2024-03-31 | $1.53B | $0.86B | 56.12% |
| 2023-12-31 | $1.54B | $0.88B | 57.37% |
| 2023-09-30 | $1.54B | $0.91B | 58.88% |
| 2023-06-30 | $1.55B | $0.93B | 60.00% |
| 2023-03-31 | $1.56B | $0.97B | 62.04% |
| 2022-12-31 | $1.56B | $0.97B | 62.26% |
| 2022-09-30 | $1.57B | $0.97B | 61.88% |
| 2022-06-30 | $1.57B | $0.97B | 62.12% |
| 2022-03-31 | $1.56B | $0.96B | 61.79% |
| 2021-12-31 | $1.54B | $0.94B | 61.18% |
| 2021-09-30 | $1.53B | $0.94B | 61.40% |
| 2021-06-30 | $1.51B | $0.93B | 61.63% |
| 2021-03-31 | $1.38B | $0.84B | 61.25% |
| 2020-12-31 | $1.37B | $0.85B | 62.03% |
| 2020-09-30 | $1.38B | $0.86B | 62.05% |
| 2020-06-30 | $1.39B | $0.86B | 61.72% |
| 2020-03-31 | $1.51B | $0.94B | 62.37% |
| 2019-12-31 | $1.52B | $0.95B | 62.78% |
| 2019-09-30 | $1.51B | $0.94B | 62.68% |
| 2019-06-30 | $1.49B | $0.93B | 62.36% |
| 2019-03-31 | $1.48B | $0.92B | 62.37% |
| 2018-12-31 | $1.47B | $0.90B | 61.28% |
| 2018-09-30 | $1.46B | $0.89B | 60.70% |
| 2018-06-30 | $1.37B | $0.84B | 61.20% |
| 2018-03-31 | $1.29B | $0.79B | 61.62% |
| 2017-12-31 | $1.19B | $0.75B | 63.25% |
| 2017-09-30 | $1.08B | $0.70B | 65.24% |
| 2017-06-30 | $1.05B | $0.69B | 65.52% |
| 2017-03-31 | $1.01B | $0.66B | 65.38% |
| 2016-12-31 | $0.99B | $0.64B | 64.82% |
| 2016-09-30 | $0.98B | $0.62B | 63.87% |
| 2016-06-30 | $0.95B | $0.60B | 63.27% |
| 2016-03-31 | $0.92B | $0.58B | 63.25% |
| 2015-12-31 | $0.88B | $0.56B | 62.85% |
| 2015-09-30 | $0.80B | $0.50B | 62.52% |
| 2015-06-30 | $0.77B | $0.48B | 62.71% |
| 2015-03-31 | $0.79B | $0.49B | 62.17% |
| 2014-12-31 | $0.80B | $0.49B | 61.98% |
| 2014-09-30 | $0.73B | $0.45B | 61.52% |
| 2014-06-30 | $0.74B | $0.45B | 61.22% |
| 2014-03-31 | $0.72B | $0.43B | 60.56% |
| 2013-12-31 | $0.70B | $0.42B | 59.83% |
| 2013-09-30 | $0.83B | $0.51B | 60.84% |
| 2013-06-30 | $0.83B | $0.51B | 61.06% |
| 2013-03-31 | $0.83B | $0.51B | 61.73% |
| 2012-12-31 | $0.83B | $0.52B | 62.41% |
| 2012-09-30 | $0.82B | $0.51B | 61.71% |
| 2012-06-30 | $0.81B | $0.50B | 61.45% |
| 2012-03-31 | $0.80B | $0.49B | 61.26% |
| 2011-12-31 | $0.78B | $0.48B | 61.67% |
| 2011-09-30 | $0.77B | $0.48B | 62.73% |
| 2011-06-30 | $0.76B | $0.48B | 63.05% |
| 2011-03-31 | $0.74B | $0.47B | 63.43% |
| 2010-12-31 | $0.73B | $0.46B | 63.17% |
| 2010-09-30 | $0.72B | $0.46B | 63.62% |
| 2010-06-30 | $0.71B | $0.45B | 63.84% |
| 2010-03-31 | $0.70B | $0.44B | 63.88% |
| 2009-12-31 | $0.68B | $0.44B | 64.13% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.701B | $1.542B |
| Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $210.506B | 96.57 |
| Thermo Fisher Scientific (TMO) | United States | $202.042B | 24.50 |
| Alcon (ALC) | Switzerland | $44.047B | 29.47 |
| Edwards Lifesciences (EW) | United States | $42.914B | 27.77 |
| IDEXX Laboratories (IDXX) | United States | $37.709B | 43.46 |
| DexCom (DXCM) | United States | $35.463B | 55.00 |
| IQVIA Holdings (IQV) | United States | $34.295B | 19.00 |
| Mettler-Toledo (MTD) | United States | $27.400B | 31.83 |
| Waters (WAT) | United States | $22.520B | 31.95 |
| STERIS (STE) | Ireland | $21.977B | 25.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.361B | 0.00 |
| Hologic (HOLX) | United States | $14.588B | 15.74 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.679B | 14.04 |
| Sysmex ADR (SSMXY) | Japan | $11.343B | 35.57 |
| Penumbra (PEN) | United States | $11.081B | 100.24 |
| Globus Medical (GMED) | United States | $10.896B | 25.48 |
| Masimo (MASI) | United States | $9.140B | 44.23 |
| Teleflex (TFX) | United States | $8.250B | 13.16 |
| Glaukos (GKOS) | United States | $6.850B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.269B | 23.96 |
| PROCEPT BioRobotics (PRCT) | United States | $3.400B | 0.00 |
| Veracyte (VCYT) | United States | $3.050B | 55.44 |
| LivaNova (LIVN) | United Kingdom | $2.688B | 15.52 |
| Nihon Kohden (NHNKY) | Japan | $2.652B | 14.49 |
| TransMedics (TMDX) | United States | $2.588B | 82.04 |
| Elekta AB (EKTAY) | Sweden | $2.198B | 19.76 |
| Tandem Diabetes Care (TNDM) | United States | $2.145B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.526B | 0.00 |
| RxSight (RXST) | United States | $1.181B | 0.00 |
| OPKO Health (OPK) | United States | $1.174B | 0.00 |
| Artivion (AORT) | United States | $1.167B | 111.40 |
| Pulse Biosciences (PLSE) | United States | $1.154B | 0.00 |
| Paragon 28 (FNA) | United States | $1.092B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.883B | 0.00 |
| AxoGen (AXGN) | United States | $0.793B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.791B | 17.30 |
| SiBone (SIBN) | United States | $0.733B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.718B | 12.21 |
| IRadimed (IRMD) | United States | $0.699B | 36.76 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.694B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.569B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.452B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.449B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.446B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.411B | 9.04 |
| AngioDynamics (ANGO) | United States | $0.408B | 0.00 |
| NeuroPace (NPCE) | United States | $0.404B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.86 |
| CVRx (CVRX) | United States | $0.343B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.261B | 0.00 |
| Inogen (INGN) | United States | $0.234B | 0.00 |
| Nevro (NVRO) | United States | $0.214B | 0.00 |
| Accuray (ARAY) | United States | $0.212B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.169B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.151B | 0.00 |
| Neuronetics (STIM) | United States | $0.135B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.125B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.121B | 0.00 |
| LENSAR (LNSR) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.099B | 0.00 |
| InspireMD (NSPR) | Israel | $0.097B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.093B | 0.00 |
| 908 Devices (MASS) | United States | $0.089B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.085B | 12.98 |
| Lucid Diagnostics (LUCD) | United States | $0.082B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.081B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.062B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.58 |
| Microbot Medical (MBOT) | United States | $0.054B | 0.00 |
| Positron (POSC) | United States | $0.052B | 0.00 |
| Spectral AI (MDAI) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.030B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.029B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.021B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.016B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.014B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.006B | 0.00 |
| Nuwellis (NUWE) | United States | $0.006B | 0.00 |
| Tenon Medical (TNON) | United States | $0.004B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |